Alaska Permanent Fund Corp 13D/13G Filings for Vir Biotechnology, Inc. (VIR)

Alaska Permanent Fund Corp 13D and 13G filings for Vir Biotechnology, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		Transaction
Date		TypeCompany
Symbol		Filed By
Symbol		Shares Owned
% Owned		Shares Vs. Prev ReportView
2021-02-16
07:08 am
Sale		2020-12-3113GVir Biotechnology, Inc.
VIR		Alaska Permanent Fund Corp3,893,040
3.060%		-1,662,516decrease
(-29.93%)		Filing
2020-05-07
07:04 am
Unchanged		2020-04-1413GVir Biotechnology, Inc.
VIR		Alaska Permanent Fund Corp5,555,556
5.060%		0
(Unchanged)		Filing